4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-23-016629
EVP & Chief Operating Officer sold 1,482 shares at $22.82 ($33,819)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Friedl-Naderer Johanna EVP & Chief Operating Officer | 2023-03-03 | Sale | −1,482 | $22.82 | $33,819 | 148,518 | D |
| Open-market sales · 1,482 sh · avg $22.82 · $33,819 | |||||||
Loading xslF345X03/doc4.xml…